CLINICAL TRIALS PROFILE FOR PIROXICAM

All Clinical Trials for Piroxicam

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00222183 ↗	Cutaneous Lupus Erythematosus and Elidel	Withdrawn	Novartis	N/A	2003-06-01	This trial evaluates the therapeutic effect of Elidel (pimecrolimus) in comparison to the corresponding vehicle in patients with chronic discoid lupus erythematosus (dLE) or subacute cutaneous lupus erythematosus (scLE).
NCT00222183 ↗	Cutaneous Lupus Erythematosus and Elidel	Withdrawn	University of Leipzig	N/A	2003-06-01	This trial evaluates the therapeutic effect of Elidel (pimecrolimus) in comparison to the corresponding vehicle in patients with chronic discoid lupus erythematosus (dLE) or subacute cutaneous lupus erythematosus (scLE).
NCT00530387 ↗	Multi-Centre European Photopatch Test Study	Completed	NHS Tayside	N/A	2008-07-01	It is known that people can develop an allergic skin reaction to a substance which is placed on the skin and then subjected to sunlight. This process is called Photocontact allergic dermatitis. It is known that people can develop Photocontact allergic dermatitis to sunscreen chemicals (filters) and also cream forms of pain-killing drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). The purpose of this study is to determine the frequency of Photocontact allergic dermatitis to 19 sunscreen filters and 5 topical NSAIDs in 1,000 European patients who present to a dermatologist with a sun-exposed site dermatitis. Each participant will have the 24 test agents plus one control of petrolatum applied to the skin of the back for 24 or 48 hours. After removal of the substances, the area of skin will be exposed to a precise amount of ultraviolet-A light. The area is then assessed 24, 48 and 72 hours later to see if a photocontact allergic reaction has occured. This method is known as photopatch testing. The study will run for one year, during which time it is planned to recruit 1,000 patients.
NCT00631514 ↗	Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Completed	Dr Ivancica Pavlicevic Family Practice Office	Phase 4	2005-01-01	NSAIDs may increase blood pressure and blunt the effects of many antihypertensives. Members of these drug classes differ in their propensity to such an interaction.
NCT00631514 ↗	Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Completed	University Hospital of Split	Phase 4	2005-01-01	NSAIDs may increase blood pressure and blunt the effects of many antihypertensives. Members of these drug classes differ in their propensity to such an interaction.
NCT00631514 ↗	Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Completed	University of Split	Phase 4	2005-01-01	NSAIDs may increase blood pressure and blunt the effects of many antihypertensives. Members of these drug classes differ in their propensity to such an interaction.

Clinical Trial Conditions for Piroxicam

Condition Name

Condition Name for Piroxicam
Intervention	Trials
Postoperative Pain	3
Renal Colic	2
Pain	2
Post-operative Endodontic Pain	1

Condition MeSH

Condition MeSH for Piroxicam
Intervention	Trials
Pulpitis	3
Pain, Postoperative	3
Neoplasm Metastasis	2
Emergencies	2

Clinical Trial Locations for Piroxicam

Trials by Country

Trials by Country for Piroxicam
Location	Trials
Brazil	10
Tunisia	3
United Kingdom	2
Pakistan	2
Germany	2

Clinical Trial Progress for Piroxicam

Clinical Trial Phase

Clinical Trial Phase for Piroxicam
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	2
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for Piroxicam
Clinical Trial Phase	Trials
Completed	18
Unknown status	5
Recruiting	3

Clinical Trial Sponsors for Piroxicam

Sponsor Name

Sponsor Name for Piroxicam
Sponsor	Trials
Fundação de Amparo à Pesquisa do Estado de São Paulo	3
University of Monastir	3
Cairo University	3

Sponsor Type

Sponsor Type for Piroxicam
Sponsor	Trials
Other	33
Industry	5